Atopic Dermatitis
European Medicines Agency recommends Dupixent for young children with atopic dermatitis
The European Medicines Agency has recommended extending Dupixent approval to treat severe atopic dermatitis in children aged 6 months to 5 years in the European Union, Regeneron Pharmaceuticals and Sanofi announced in a press release.
Rural infants show greater skin barrier impairment at birth than urban infants
Infants living in urban areas had lower transepidermal water loss values than infants in rural areas, according to a letter published in Pediatric Allergy and Asthma.
Topical brepocitinib efficacious in treatment of atopic dermatitis
Previously administered orally, brepocitinib proved to be effective and well tolerated as a topical formation in patients with mild to moderate atopic dermatitis, according to a phase 2b study.
Heated tobacco product use in pregnancy associated with allergic disease in offspring
Smoking heated tobacco products during pregnancy was associated with allergy — specifically asthma, rhinitis and conjunctivitis, and atopic dermatitis — in offspring, according to a study published in Allergy.
Targeting IL-13 with tralokinumab may improve microbial dysbiosis in atopic dermatitis
Tralokinumab, a high-affinity monoclonal antibody that specifically neutralizes interleukin-13, improved microbial diversity and reduced Staphylococcus aureus among patients with moderate to severe atopic dermatitis, according to a study.
Top 2022 stories highlighting COVID-19 impact on asthma, allergy
Nearly 3 years into the pandemic, COVID-19 continues to dominate headlines and research labs as scientists explore therapies that mitigate the impact of the virus, particularly among patients with asthma and allergy.
Roflumilast cream effective, tolerable in adults, children aged at least 6 years
Arcutis Biotherapeutics announced positive topline results from its phase 3 trial of roflumilast cream in adults and children aged 6 years and older with mild to moderate atopic dermatitis, according to a company press release.
Wearable digital technology measures atopic dermatitis itch while sleeping
LOUISVILLE, Ky. — The use of wearable digital health monitors that measure itch and scratch during sleep appeared useful for patients with atopic dermatitis, according to study results.
New drug effective, safe in long-term treatment of moderate to severe atopic dermatitis
Patients with moderate to severe atopic dermatitis showed promising results during and up to 20 weeks after treatment in a clinical trial evaluating rocatinlimab, according to a study.
Eczema tops reasons why pediatricians order food allergy IgE panels
LOUISVILLE, Ky. — Eczema was the top non-IgE mediated indication pediatricians at a health care network used for food allergy IgE panel testing, according to study results.